GHK-Cu (50mg)
$49.99
GHK-Cu (Glycine-Histidine-Lysine Copper) is a naturally occurring copper-binding tripeptide found in human plasma, saliva, and urine. In research settings, GHK-Cu is studied for its interactions with collagen synthesis pathways, fibroblast activity, angiogenesis signaling, and extracellular matrix remodeling in tissue biology models.
BioRhex supplies GHK-Cu as a research compound manufactured in a GMP-compliant US facility, tested to ≥99% purity via HPLC and mass spectrometry, and supplied strictly for controlled laboratory research — not for human or animal use.
- In stock
- COA-verified
- ≥99% purity.
- USA manufactured.
- In stock
- COA-verified
- ≥99% purity.
- USA manufactured.
- COA-verified
- In stock
- ≥99% purity.
- USA manufactured.
What Is GHK-Cu?
GHK-Cu (Glycine-Histidine-Lysine Copper) is a naturally occurring copper-binding tripeptide found in human plasma, saliva, and urine. In research settings, GHK-Cu is studied for its interactions with collagen synthesis pathways, fibroblast activity, angiogenesis signaling, and extracellular matrix remodeling in tissue biology models.
BioRhex supplies GHK-Cu as a research compound manufactured in a GMP-compliant US facility, tested to ≥99% purity via HPLC and mass spectrometry, and supplied strictly for controlled laboratory research — not for human or animal use.
Compound Overview
GHK-Cu is a copper peptide complex studied for its tissue signaling and ECM biology properties. In vitro and preclinical research models examine how GHK-Cu may influence:
• Collagen I, III, and elastin synthesis pathway activation in fibroblast models
• Angiogenesis signaling and endothelial cell pathway activity
• Matrix metalloproteinase (MMP) regulation and ECM remodeling dynamics
• Antioxidant enzyme expression and oxidative stress pathway signaling
• Dermal cell proliferation and wound healing pathway modeling
All findings referenced are from controlled research environments and do not represent clinical outcomes or therapeutic claims.
History of GHK-Cu
GHK-Cu was first identified by Loren Pickart in 1973 during research into plasma factors influencing liver tissue responses. The tripeptide’s copper-binding properties and associated biological signaling activity were characterized through subsequent investigations.
Research demonstrated GHK-Cu’s interactions with collagen synthesis pathways, wound healing signaling, and tissue remodeling biology — establishing it as a research tool in dermal and connective tissue research.
It remains one of the more studied naturally occurring copper peptides in tissue repair biology and dermal signaling research within laboratory settings.
Molecular Structure
Gly-His-Lys · Cu²⁺
Research Findings
Published and preclinical research on GHK-Cu covers several areas of scientific investigation, including:
Collagen synthesis research: Studies examine how GHK-Cu modulates collagen I, III, and IV production pathways in fibroblast and dermal cell models.
Wound healing pathway modeling: Research investigates GHK-Cu’s interactions with keratinocyte migration, fibroblast activation, and wound contraction signaling.
Angiogenesis research: Laboratory models explore GHK-Cu’s effects on VEGF expression and endothelial cell activity in tissue biology research.
MMP regulation research: Studies evaluate GHK-Cu’s effects on matrix metalloproteinase activity and ECM remodeling dynamics in tissue models.
All findings referenced are from controlled, non-clinical research models and do not imply therapeutic or clinical application.
References
FAQ
Q: What type of research is GHK-Cu used for?
Q: What type of research is GHK-Cu used for?
A: GHK-Cu is used in laboratory research settings. All supplied compounds are intended strictly for in vitro and preclinical research purposes. Use is limited to controlled scientific environments.
Q: Where is BioRhex’s GHK-Cu manufactured?
Q: Where is BioRhex’s GHK-Cu manufactured?
A: All BioRhex compounds, including GHK-Cu, are manufactured in a GMP-compliant facility located in the United States.
Q: What testing does BioRhex conduct on GHK-Cu?
Q: What testing does BioRhex conduct on GHK-Cu?
A: Every batch of GHK-Cu undergoes third-party HPLC purity testing, mass spectrometry identity verification, and sterility testing. A Certificate of Analysis is included with every order, documenting batch-specific purity data at a ≥99% threshold.
Q: Is GHK-Cu approved for human use?
Q: Is GHK-Cu approved for human use?
A: No. GHK-Cu is not FDA-approved and is not intended for human or animal administration. It is supplied exclusively for laboratory research purposes.
Q: Who should handle this compound?
Q: Who should handle this compound?
A: Only qualified personnel in controlled laboratory settings following appropriate safety and handling protocols.
Research Use Only
All BioRhex compounds are supplied strictly for laboratory research purposes. Not for human or animal consumption, medical use, or therapeutic application. GHK-Cu is not FDA-approved for any medical purpose. Nothing on this page should be interpreted as health guidance or applied outside controlled research settings.
RELATED PRODUCTS
AOD9604 (5mg)
BPC-157
BPC-157 + TB-500
CJC (no DAC) + Ipamorelin (10mg)
